Aardvark Therapeutics, Inc. Common Stock (AARD) is a Healthcare · Biotechnology company listed on NASDAQ. Price $5.30 (-4.16%), Market cap $0.15B, 52-week low–high $3.51 ~ $17.41.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for Aardvark Therapeutics, Inc. Common Stock are updated in real time on BlackAll Trade.
Aardvark Therapeutics, Inc. Common Stock trades at $5.30 (-4.16%). Real-time quotes and charts are available on BlackAll Trade.
Aardvark Therapeutics, Inc. Common Stock has a market cap of about $0.15B.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseas